Government and Regulations

FDA announces new potential side effects for varenicline


 

References

The Food and Drug Administration is warning physicians and patients that taking varenicline for smoking cessation can change a patient’s reaction to alcohol and can cause seizures* in patients without prior history.

Some patients who have drunk alcohol while taking varenicline, marketed as Chantix, have reported decreased tolerance to alcohol, including symptoms such as increased drunkenness, unusual or aggressive behavior, or memory loss. Patients have also reported incidence of seizure within a month of starting varenicline, despite having no previous history of seizure.

“Until patients know how Chantix affects their ability to tolerate alcohol, they should decrease the amount of alcohol they drink. Patients who have a seizure while taking Chantix should stop the medicine and seek medical attention immediately,” the FDA recommended.

Find the full announcement on the FDA website.

*Correction, 3/11/2015: An earlier version of this article misstated one of the side effects of varenicline.

Recommended Reading

CDC: Flu remains widespread; antivirals underutilized
MDedge Emergency Medicine
So far, flu vaccine only 23% effective
MDedge Emergency Medicine
Hospitalization for pneumonia raises CVD risk
MDedge Emergency Medicine
Lighter ventilator sedation protocol no better than usual care in the PICU
MDedge Emergency Medicine
FDA panel backs antifungal for invasive aspergillosis, mucormycosis
MDedge Emergency Medicine
Meta-analysis: Oseltamivir shortens time to flu relief
MDedge Emergency Medicine
Methylprednisolone cuts treatment failure in severe CAP
MDedge Emergency Medicine
Health care association transmission major factor in MERS-CoV outbreak
MDedge Emergency Medicine
Environmental factors could increase U.S. anthrax cases
MDedge Emergency Medicine
FDA panel recommends two new strains for 2015-2016 influenza vaccines
MDedge Emergency Medicine